HeartCore’s Client SBC Medical Debuts on Nasdaq

HeartCore Enterprises, Inc. has announced that its client, SBC Medical Group, has started trading on Nasdaq with the ticker “SBC.” HeartCore earned $17.9 million from the deal, with $17 million accounted for in Q3 2024 and holds $8 million in SBC stock after a successful IPO process. The company expects a record-breaking Q3 with revenues of $19 million to $23 million and net profits between $4 million and $8 million, marking a significant year-over-year growth.